Product
adavosertib
Aliases
MK-1775
3 clinical trials
3 indications
Indication
Cervical CancerIndication
Solid TumorsIndication
Ovarian CancerClinical trial
A Two Part, Phase I-IIa Study Evaluating MK1775 in Combination With Topotecan/Cisplatin in Adult Patients With Cervical CancerStatus: Terminated, Estimated PCD: 2011-06-13
Clinical trial
A Phase I Dose Escalation Study Evaluating MK-1775 in Both Monotherapy and in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adult Subjects With Advanced Solid TumorsStatus: Completed, Estimated PCD: 2014-01-06
Clinical trial
A Randomized, Phase II Study Evaluating MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Adult Patients With Platinum Sensitive p53 Mutant Ovarian CancerStatus: Completed, Estimated PCD: 2016-08-08